US FDA Approves Glenmark Pharma’s Generic Antibiotic Drug
Glenmark Pharma has announced that the US Food and Drug Administration (USFDA) has granted it permission to distribute a generic version of Pfizer’s antibiotic Cleocin capsules. Clindamycin Hydrochloride Capsules with potencies of 75 mg, 150 mg, and 300 mg will be distributed in the United States by Glenmark Pharmaceuticals Inc, an Indian subsidiary. This endorsement […]
Continue Reading